Essex LLC Johnson & Johnson Transaction History

Essex LLC

$482 Million
Q3 2024

A detailed history of Essex LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Essex LLC holds 29,540 shares of JNJ stock, worth $4.59 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

29,540

Previous 31,059 4.89%

Holding current value

$4.59 Million

Previous $4.54 Million 5.46%

% of portfolio

0.99%

Previous 1.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$145.48 - $167.38 $220,984 - $254,250	-1,519 Reduced 4.89%	29,540 $4.79 Million
Q2 2024 Jul 22, 2024	SELL	$144.38 - $157.78 $164,015 - $179,238	-1,136 Reduced 3.53%	31,059 $4.54 Million
Q1 2024 May 03, 2024	SELL	$155.22 - $162.74 $62,708 - $65,746	-404 Reduced 1.24%	32,195 $5.09 Million
Q4 2023 Jan 29, 2024	BUY	$145.6 - $158.88 $5,096 - $5,560	35 Added 0.11%	32,599 $5.11 Million
Q3 2023 Oct 16, 2023	BUY	$155.75 - $174.48 $276,456 - $309,702	1,775 Added 5.77%	32,564 $5.07 Million
Q2 2023 Jul 31, 2023	SELL	$154.35 - $166.11 $145,860 - $156,973	-945 Reduced 2.98%	30,789 $5.1 Million
Q4 2022 Jan 30, 2023	BUY	$160.2 - $179.79 $640 - $719	4 Added 0.01%	31,734 $5.61 Million
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $135,033 - $150,258	-837 Reduced 2.57%	31,730 $5.18 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $49,279 - $54,500	293 Added 0.91%	32,567 $5.78 Million
Q1 2022 Apr 20, 2022	BUY	$158.14 - $179.59 $181,228 - $205,810	1,146 Added 3.68%	32,274 $5.72 Million
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $107,747 - $119,549	691 Added 2.27%	31,128 $5.33 Million
Q3 2021 Oct 21, 2021	BUY	$161.5 - $179.47 $4.92 Million - $5.46 Million	30,437 New	30,437 $4.92 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.

Account